Product Code: GVR-4-68039-994-7
Needle-free Injectors Market Growth & Trends:
The global needle-free injectors market size is expected to reach USD 2.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2022 to 2030. Increasing prevalence of chronic diseases and rising patient volume are factors projected to enhance the demand for needle-free injectors.
As a result of a sedentary lifestyle, the prevalence of lifestyle-associated diseases such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters such as blood pressure and blood sugar levels. This allows integration of healthcare data with portable devices such as needle-free injectors and further this can be forwarded to physicians or doctors in order to have real-time access to data and reduce errors, thereby expected to propel the demand for needle-free injectors.
The global needle-free injectors market is expected to witness lucrative growth owing to growing geriatric population coupled with rise in prevalence of chronic diseases such as cancer, diabetes, neurological disorders, hypertension, and age-related orthopedic disorders. In addition, increasing awareness, coupled with rise in adoption of needle-free injectors, is expected to promote market growth.
Constant rise in geriatric population base is aggregating the financial demands on the health care system. According to the Population Reference Bureau, the number of Americans aged 65 and above is predicted to nearly double from 52 million in 2018 to 95 million by 2060. Such rise in elderly population base will subsequently result in greater demand for needle-free injectors, hence predicting to enhance the market progression.
Needle-free Injectors Market Report Highlights:
- The powder-based needle-free injectors segment held the largest market share in 2022 owing to the rising demand for these injectors among individuals
- The disposable segment held significant market share in 2022 due to the ease of use and presence of a built-in glass syringe that minimizes the need to manually load the glass syringe, ultimately making it convenient for patients
- The pain management segment is anticipated to gain the highest market share during the forecast period due to the increasing number of pain-related cases all across the globe
- North America is the leading market in 2022 owing to favorable regulatory reimbursement and growing demand for needle-free injectors
- Asia Pacific is expected to witness the fastest growth rate during the forecast period due to the availability of low-cost labor for manufacturing across several countries of Asia
Table of Contents
Chapter 1 Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Type
- 1.1.3. Technology
- 1.1.4. Delivery Site
- 1.1.5. Usability
- 1.1.6. Application
- 1.1.7. End-use
- 1.1.8. Regional scope
- 1.1.9. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1.1. Commodity flow analysis (Model 1)
- 1.6.1.2. Approach 1: Commodity flow approach
- 1.6.1.3. Volume price analysis (Model 2)
- 1.6.1.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2 Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Type outlook
- 2.2.3. Technology outlook
- 2.2.4. Delivery site outlook
- 2.2.5. Usability outlook
- 2.2.6. Application outlook
- 2.2.7. End-use outlook
- 2.2.8. Regional outlook
- 2.3. Competitive Insights
Chapter 3 Needle-free Injectors Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing prevalence of chronic disorders
- 3.4.1.2. Technological advancements
- 3.4.1.3. Increasing cases of needle-stick injures
- 3.4.2. Market restraint analysis
- 3.4.2.1. Lack of awareness in developing and underdeveloped economies
- 3.4.2.2. Stringent regulations
- 3.5. Needle-free Injectors Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier product
- 3.5.1.2. Buyer product
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4 Needle-free Injectors: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Fillable
- 4.1.2. Prefilled
- 4.2. Product Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Needle-free Injectors Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Fillable
- 4.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 4.5.2. Prefilled
- 4.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 5 Needle-free Injectors: Usability Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Disposable
- 5.1.2. Reusable
- 5.2. Usability Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Needle-free Injectors Market by Usability Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Disposable
- 5.5.1.1. Market estimates and forecast 2018 to 2030, (USD million)
- 5.5.2. Reusable
- 5.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 6 Needle-free Injectors: Application Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Vaccine Delivery
- 6.1.2. Insulin Delivery
- 6.1.3. Pain Management
- 6.1.4. Others
- 6.2. Application Market Share, 2022 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Needle-free Injectors Market by Application Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Vaccine delivery
- 6.5.1.1. Market estimates and forecast 2018 to 2030, (USD million)
- 6.5.2. Insulin delivery
- 6.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 6.5.3. Pain management
- 6.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 6.5.4. Others
- 6.5.4.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 7 Needle-free Injectors: Technology Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.1.1. Spring-based needle-free injectors
- 7.1.2. Gas-powered needle-free injectors
- 7.1.3. Laser-powered needle-free injectors
- 7.1.4. Vibration-based needle-free injectors
- 7.2. Technology Market Share, 2022 & 2030
- 7.3. Segment Dashboard
- 7.4. Global Needle-free Injectors Market by Technology Outlook
- 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5.1. Spring-based needle-free injectors
- 7.5.1.1. Market estimates and forecast 2018 to 2030, (USD million)
- 7.5.2. Gas-powered needle-free injectors
- 7.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 7.5.3. Laser-powered needle-free injectors
- 7.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 7.5.4. Vibration-based needle-free injectors
- 7.5.4.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 8 Needle-free Injectors: Type Estimates & Trend Analysis
- 8.1. Definitions and Scope
- 8.1.1. Powder-based needle free injectors
- 8.1.2. Liquid-based needle free injectors
- 8.1.3. Projectile/depot-based needle free injectors
- 8.2. Type Market Share, 2022 & 2030
- 8.3. Segment Dashboard
- 8.4. Global Needle-free Injectors Market by Type Outlook
- 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.5.1. Powder-based needle free injectors
- 8.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 8.5.2. Liquid-based needle free injectors
- 8.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 8.5.3. Projectile/depot-based needle free injectors
- 8.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 9 Needle-free Injectors: Delivery Site Estimates & Trend Analysis
- 9.1. Definitions and Scope
- 9.1.1. Subcutaneous
- 9.1.2. Intramuscular
- 9.1.3. Intradermal
- 9.2. Delivery Site Market Share, 2022 & 2030
- 9.3. Segment Dashboard
- 9.4. Global Needle-free Injectors Market by Delivery Site Outlook
- 9.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 9.5.1. Subcutaneous
- 9.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 9.5.2. Intramuscular
- 9.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 9.5.3. Intradermal
- 9.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 10 Needle-free Injectors: End-use Estimates & Trend Analysis
- 10.1. Definitions and Scope
- 10.1.1. Hospitals & Clinics
- 10.1.2. Home Care Settings
- 10.1.3. Research Laboratories
- 10.2. End-use Market Share, 2022 & 2030
- 10.3. Segment Dashboard
- 10.4. Global Needle-free Injectors Market by End-use Outlook
- 10.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 10.5.1. Hospitals & clinics
- 10.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 10.5.2. Home care settings
- 10.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
- 10.5.3. Research laboratories
- 10.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 11 Needle-free Injectors Market: Regional Estimates & Trend Analysis
- 11.1. Regional market share analysis, 2022 & 2030
- 11.2. Regional Market Dashboard
- 11.3. Global Regional Market Snapshot
- 11.4. Regional Market Share and Leading Players, 2022
- 11.4.1. North America
- 11.4.2. Europe
- 11.4.3. Asia Pacific
- 11.4.4. Latin America
- 11.4.5. Middle East and Africa
- 11.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 11.5.1. North America
- 11.5.2. Europe
- 11.5.3. Asia Pacific
- 11.5.4. Latin America
- 11.5.5. Middle East and Africa
- 11.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
- 11.7. North America
- 11.7.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.7.2. U.S.
- 11.7.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.7.3. Canada
- 11.7.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.8. Europe
- 11.8.1. U.K.
- 11.8.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.8.2. Germany
- 11.8.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.8.3. France
- 11.8.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.8.4. Italy
- 11.8.4.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.8.5. Spain
- 11.8.5.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.9. Asia Pacific
- 11.9.1. China
- 11.9.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.9.2. Japan
- 11.9.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.9.3. India
- 11.9.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.9.4. South Korea
- 11.9.4.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.9.5. Australia
- 11.9.5.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.10. Latin America
- 11.10.1. Brazil
- 11.10.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.10.2. Mexico
- 11.10.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.10.3. Argentina
- 11.10.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.10.4. Colombia
- 11.10.4.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.11. MEA
- 11.11.1. Saudi Arabia
- 11.11.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.11.2. South Africa
- 11.11.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 11.11.3. UAE
- 11.11.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
Chapter 12 Competitive Landscape
- 12.1. Recent Developments & Impact Analysis, By Key Market Participants
- 12.2. Company/Competition Categorization
- 12.3. Vendor Landscape
- 12.3.1. List of key distributors and channel partners
- 12.3.2. Key customers
- 12.3.3. Key company market share analysis, 2022
- 12.3.4. PharmaJet.
- 12.3.4.1. Company overview
- 12.3.4.2. Financial performance
- 12.3.4.3. Product benchmarking
- 12.3.4.4. Strategic initiatives
- 12.3.5. Crossject
- 12.3.5.1. Company overview
- 12.3.5.2. Financial performance
- 12.3.5.3. Product benchmarking
- 12.3.5.4. Strategic initiatives
- 12.3.6. Portal Instruments
- 12.3.6.1. Company overview
- 12.3.6.2. Financial performance
- 12.3.6.3. Product benchmarking
- 12.3.6.4. Strategic initiatives
- 12.3.7. NuGen Medical Devices
- 12.3.7.1. Company overview
- 12.3.7.2. Financial performance
- 12.3.7.3. Product benchmarking
- 12.3.7.4. Strategic initiatives
- 12.3.8. Inovio Pharmaceuticals
- 12.3.8.1. Company overview
- 12.3.8.2. Financial performance
- 12.3.8.3. Product benchmarking
- 12.3.8.4. Strategic initiatives
- 12.3.9. Antares Pharma, Inc
- 12.3.9.1. Company overview
- 12.3.9.2. Financial performance
- 12.3.9.3. Product benchmarking
- 12.3.9.4. Strategic initiatives
- 12.3.10. Aijex Pharma International Inc.
- 12.3.10.1. Company overview
- 12.3.10.2. Financial performance
- 12.3.10.3. Product benchmarking
- 12.3.10.4. Strategic initiatives
- 12.3.11. Ferring B.V.
- 12.3.11.1. Company overview
- 12.3.11.2. Financial performance
- 12.3.11.3. Product benchmarking
- 12.3.11.4. Strategic initiatives
- 12.3.12. Penjet Corporation
- 12.3.12.1. Company overview
- 12.3.12.2. Financial performance
- 12.3.12.3. Product benchmarking
- 12.3.12.4. Strategic initiatives
- 12.3.13. Medical International Technology Inc.
- 12.3.13.1. Company overview
- 12.3.13.2. Financial performance
- 12.3.13.3. Product benchmarking
- 12.3.13.4. Strategic initiatives